Parnell Pharmaceuticals Priced, Nasdaq: PARN
Australian maker of osteoarthritis and reproductive drugs for dogs, horses and cows.
Industry: Health Care
First Day Return: -19.5%
Industry: Health Care
PARN
Australian maker of osteoarthritis and reproductive drugs for dogs, horses and cows.
| IPO Data | |
|---|---|
| IPO File Date | 05/19/2014 |
| Offer Price | $10.00 |
| Price Range $10.00 - $10.00 | |
| Offer Shares (mm) | 5.0 |
| Deal Size ($mm) | $50 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 06/18/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $50 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Alexandria, Australia |
| Founded | 1986 |
| Employees at IPO | 55 |
| Website www.parnell.com | |
IPO News for Parnell Pharmaceuticals
Parnell Pharmaceuticals (PARN) Performance
